Moderna, U.S. clash in patent dispute over origins of COVID-19 vaccine: reportnews2021-11-10T15:56:55+00:00November 10th, 2021|Fierce Pharma|
AstraZeneca, FibroGen hope to keep their roxadustat dream alive with new FDA meetingnews2021-11-10T14:40:20+00:00November 10th, 2021|Fierce Pharma|
AstraZeneca creates unit to handle its COVID-19 vaccines and antibody treatmentsnews2021-11-09T20:40:42+00:00November 9th, 2021|Fierce Pharma|
AstraZeneca creates unit to handle its COVID-19 vaccines, antibody treatmentsnews2021-11-09T20:40:42+00:00November 9th, 2021|Fierce Pharma|
Johnson & Johnson scores reversal of landmark $465M opioid ruling in Oklahomanews2021-11-09T19:27:05+00:00November 9th, 2021|Fierce Pharma|
Regeneron and Novo Nordisk hold tight at the top spots on October list of biggest TV ad spendersnews2021-11-09T17:25:27+00:00November 9th, 2021|Fierce Pharma|
Biogen’s Aduhelm records one patient death. Is the controversial Alzheimer’s drug to blame?news2021-11-09T16:35:15+00:00November 9th, 2021|Fierce Pharma|
As BioNTech raises expected COVID-19 vaccine sales to $19.6B, CEO stumps for wider booster usenews2021-11-09T16:21:54+00:00November 9th, 2021|Fierce Pharma|
Judge overturns $2.4M whistleblower retaliation verdict against AstraZenecanews2021-11-09T15:47:15+00:00November 9th, 2021|Fierce Pharma|
Bayer’s Kerendia/SGLT2 combo exceeds expectations, with more expansion ahead: pharma chiefnews2021-11-09T15:20:44+00:00November 9th, 2021|Fierce Pharma|
